Zivo Bioscience, Inc. Warrants
ZIVOW
ZIVOW was delisted on the 24th of November, 2023.
3 hedge funds and large institutions have $118K invested in Zivo Bioscience, Inc. Warrants in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$63.4K |
| 2 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$39.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$1.31K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CH
1
CVI Holdings
Wilmington,
Delaware
| $72K | +$63.4K | +48,000 | New |
|
|
WAM
2
Warberg Asset Management
Winnetka,
Illinois
| $45K | +$39.6K | +30,000 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $1K | +$1.31K | +990 | New |
|
ZIVOW Hedge Fund Activity: Q2 2021 in Review
3 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Zivo Bioscience, Inc. Warrants (ZIVOW) for Q2 2021, worth a combined $118K.
Buyers outnumbered sellers: 3 funds opened new ZIVOW positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was CVI Holdings, opening a new position worth an estimated $63.4K.
- 3 institutional investors held Zivo Bioscience, Inc. Warrants (ZIVOW) as of Q2 2021, up from 0 in Q1 2021.
- Funds reported $118K of Zivo Bioscience, Inc. Warrants stock for Q2 2021.
- 3 funds opened new Zivo Bioscience, Inc. Warrants positions in Q2 2021 and 0 closed out, a net change of +3 holders.
- The largest Zivo Bioscience, Inc. Warrants buyer in Q2 2021 was CVI Holdings, an estimated $63.4K added.
Based on aggregated 13F filings for Q2 2021.